Therefore, while NfL as well as glial fibrillary acidic protein (GFAP) have been promoted as part of the AD plasma 94 biomarker diagnostic panel, they are not critical for diagnosis of AD. The gene discussed is NEFL; the disease is Alzheimer disease.